Mitochondrial genetic diseases

Alice Wong, Gino A Cortopassi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter presents an overview of the major diseases that result from mitochondrial DNA (mtDNA) mutations. The mutations are divided into two types: mutations that affect mitochondrial protein-encoding genes and those that affect mitochondrial protein synthesis. Diseases that result from mutations in mitochondrial protein-encoding genes include Leber's hereditary optic neuropathy (LHON) and neuropathy, ataxia, and retinitis pigmentosa (NARP). The diseases that result from mutations in mitochondrial protein synthesis genes include Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), progressive external ophthalmoplegia (PEO), myoclonic epilepsy and ragged red fibers (MERRF), and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Defective mitochondrial function caused by nuclear DNA mutations also leads to some mitochondrial genetic diseases. Mutations in OPA1, a mitochondrial dynamin-related guanosine triphosphatase (GTPase), have been demonstrated in patients with dominant optic atrophy (DOA), one of the most frequently occurring optic neuropathies. Friedreich's ataxia (FRDA) results from an abnormal GAA triplet repeat expansion in the first intron of the frataxin gene, resulting in decreased frataxin expression. Frataxin is a mitochondrial protein whose precise function remains unknown.

Original languageEnglish (US)
Title of host publicationNeurobiology of Disease
PublisherElsevier Inc.
Pages157-161
Number of pages5
ISBN (Print)9780120885923
DOIs
StatePublished - 2007

Fingerprint

Mitochondrial Diseases
Inborn Genetic Diseases
Mitochondrial Proteins
Mutation
Chronic Progressive External Ophthalmoplegia
Genes
MERRF Syndrome
Autosomal Dominant Optic Atrophy
Kearns-Sayre Syndrome
MELAS Syndrome
Leber's Hereditary Optic Atrophy
Friedreich Ataxia
Dynamins
Trinucleotide Repeats
Optic Nerve Diseases
Guanosine
Mitochondrial DNA
Introns
DNA

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Wong, A., & Cortopassi, G. A. (2007). Mitochondrial genetic diseases. In Neurobiology of Disease (pp. 157-161). Elsevier Inc.. https://doi.org/10.1016/B978-012088592-3/50016-5

Mitochondrial genetic diseases. / Wong, Alice; Cortopassi, Gino A.

Neurobiology of Disease. Elsevier Inc., 2007. p. 157-161.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wong, A & Cortopassi, GA 2007, Mitochondrial genetic diseases. in Neurobiology of Disease. Elsevier Inc., pp. 157-161. https://doi.org/10.1016/B978-012088592-3/50016-5
Wong A, Cortopassi GA. Mitochondrial genetic diseases. In Neurobiology of Disease. Elsevier Inc. 2007. p. 157-161 https://doi.org/10.1016/B978-012088592-3/50016-5
Wong, Alice ; Cortopassi, Gino A. / Mitochondrial genetic diseases. Neurobiology of Disease. Elsevier Inc., 2007. pp. 157-161
@inbook{f743dca9fb464a61b8bd6e0cd558175a,
title = "Mitochondrial genetic diseases",
abstract = "This chapter presents an overview of the major diseases that result from mitochondrial DNA (mtDNA) mutations. The mutations are divided into two types: mutations that affect mitochondrial protein-encoding genes and those that affect mitochondrial protein synthesis. Diseases that result from mutations in mitochondrial protein-encoding genes include Leber's hereditary optic neuropathy (LHON) and neuropathy, ataxia, and retinitis pigmentosa (NARP). The diseases that result from mutations in mitochondrial protein synthesis genes include Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), progressive external ophthalmoplegia (PEO), myoclonic epilepsy and ragged red fibers (MERRF), and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Defective mitochondrial function caused by nuclear DNA mutations also leads to some mitochondrial genetic diseases. Mutations in OPA1, a mitochondrial dynamin-related guanosine triphosphatase (GTPase), have been demonstrated in patients with dominant optic atrophy (DOA), one of the most frequently occurring optic neuropathies. Friedreich's ataxia (FRDA) results from an abnormal GAA triplet repeat expansion in the first intron of the frataxin gene, resulting in decreased frataxin expression. Frataxin is a mitochondrial protein whose precise function remains unknown.",
author = "Alice Wong and Cortopassi, {Gino A}",
year = "2007",
doi = "10.1016/B978-012088592-3/50016-5",
language = "English (US)",
isbn = "9780120885923",
pages = "157--161",
booktitle = "Neurobiology of Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Mitochondrial genetic diseases

AU - Wong, Alice

AU - Cortopassi, Gino A

PY - 2007

Y1 - 2007

N2 - This chapter presents an overview of the major diseases that result from mitochondrial DNA (mtDNA) mutations. The mutations are divided into two types: mutations that affect mitochondrial protein-encoding genes and those that affect mitochondrial protein synthesis. Diseases that result from mutations in mitochondrial protein-encoding genes include Leber's hereditary optic neuropathy (LHON) and neuropathy, ataxia, and retinitis pigmentosa (NARP). The diseases that result from mutations in mitochondrial protein synthesis genes include Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), progressive external ophthalmoplegia (PEO), myoclonic epilepsy and ragged red fibers (MERRF), and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Defective mitochondrial function caused by nuclear DNA mutations also leads to some mitochondrial genetic diseases. Mutations in OPA1, a mitochondrial dynamin-related guanosine triphosphatase (GTPase), have been demonstrated in patients with dominant optic atrophy (DOA), one of the most frequently occurring optic neuropathies. Friedreich's ataxia (FRDA) results from an abnormal GAA triplet repeat expansion in the first intron of the frataxin gene, resulting in decreased frataxin expression. Frataxin is a mitochondrial protein whose precise function remains unknown.

AB - This chapter presents an overview of the major diseases that result from mitochondrial DNA (mtDNA) mutations. The mutations are divided into two types: mutations that affect mitochondrial protein-encoding genes and those that affect mitochondrial protein synthesis. Diseases that result from mutations in mitochondrial protein-encoding genes include Leber's hereditary optic neuropathy (LHON) and neuropathy, ataxia, and retinitis pigmentosa (NARP). The diseases that result from mutations in mitochondrial protein synthesis genes include Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), progressive external ophthalmoplegia (PEO), myoclonic epilepsy and ragged red fibers (MERRF), and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Defective mitochondrial function caused by nuclear DNA mutations also leads to some mitochondrial genetic diseases. Mutations in OPA1, a mitochondrial dynamin-related guanosine triphosphatase (GTPase), have been demonstrated in patients with dominant optic atrophy (DOA), one of the most frequently occurring optic neuropathies. Friedreich's ataxia (FRDA) results from an abnormal GAA triplet repeat expansion in the first intron of the frataxin gene, resulting in decreased frataxin expression. Frataxin is a mitochondrial protein whose precise function remains unknown.

UR - http://www.scopus.com/inward/record.url?scp=84884027379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884027379&partnerID=8YFLogxK

U2 - 10.1016/B978-012088592-3/50016-5

DO - 10.1016/B978-012088592-3/50016-5

M3 - Chapter

AN - SCOPUS:84884027379

SN - 9780120885923

SP - 157

EP - 161

BT - Neurobiology of Disease

PB - Elsevier Inc.

ER -